[Concern of pharmacovigilance: proarrhythmic effects of medications in current use].
Caron
J
J
Centre régional de pharmacovigilance, CHRU de Lille, France.
Gautier
S
S
Couderc
E
E
Bordet
R
R
D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001281:Atrial Fibrillation / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D013610:Tachycardia / Q000139:chemically induced
De l'intérêt de la pharmacovigilance: effets proarythmiques de médicaments d'usage courant.